ProfileGDS5822 / ILMN_2688607
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 94% 96% 95% 95% 95% 95% 95% 94% 93% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11015.594
GSM1276600PDAC Late Ablation Control 21506.696
GSM1276601PDAC Late Ablation Control 31376.695
GSM1276602PDAC Late Ablation 11089.795
GSM1276603PDAC Late Ablation 21141.195
GSM1276604PDAC Late Ablation 31533.895
GSM1303940PDAC Late Ablation_anti-CTLA4 11247.695
GSM1303941PDAC Late Ablation_anti-CTLA4 2119194
GSM1303942PDAC Late Ablation_anti-CTLA4 3930.493